103 related articles for article (PubMed ID: 8988509)
41. Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Golden DW; Rudra S; Witt ME; Nwizu T; Cohen EE; Blair E; Stenson KM; Vokes EE; Haraf DJ
Oral Oncol; 2013 Mar; 49(3):277-82. PubMed ID: 23102863
[TBL] [Abstract][Full Text] [Related]
42. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
43. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
[TBL] [Abstract][Full Text] [Related]
44. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
45. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
[TBL] [Abstract][Full Text] [Related]
46. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
47. [Concurrent chemoradiotherapy with sodium glycididazole and cisplatin for local advanced nasopharyngeal carcinoma].
He ZY; Li FY; Tong Q; Liao ZW; Guan XX; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2038-40. PubMed ID: 19033122
[TBL] [Abstract][Full Text] [Related]
48. Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma.
Ekenel M; Keskin S; Basaran M; Ozdemir C; Meral R; Altun M; Aslan I; Bavbek SE
Oral Oncol; 2011 Jul; 47(7):660-4. PubMed ID: 21596616
[TBL] [Abstract][Full Text] [Related]
49. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
[TBL] [Abstract][Full Text] [Related]
50. Choroid metastasis of undifferentiated nasopharyngeal carcinoma.
Ozyar E; Kiratli H; Akbulut S; Uzal D; Atahan IL
J Laryngol Otol; 1998 Jul; 112(7):667-9. PubMed ID: 9775302
[TBL] [Abstract][Full Text] [Related]
51. [Clinical assessment of bone scanning in 78 patients with nasopharyngeal carcinoma after radiotherapy].
Ouyang L; Ouyang X; Guan C; Li J; Lin C
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(2):72-3. PubMed ID: 15844581
[TBL] [Abstract][Full Text] [Related]
52. Prolonged survival in a nasopharyngeal carcinoma patient with multiple metastases: a case report and review of the literature.
Chou CW; Liu JM; Wu MF; Li AF; Tie CM; Chi KH
Jpn J Clin Oncol; 1997 Oct; 27(5):336-9. PubMed ID: 9390212
[TBL] [Abstract][Full Text] [Related]
53. [Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum].
Penel N; Kouto H; Ala-Eddine C; Degardin M
Rev Med Interne; 2002 Mar; 23(3):337-9. PubMed ID: 11928386
[No Abstract] [Full Text] [Related]
54. Bone marrow biopsies in patients with undifferentiated carcinoma of the nasopharyngeal type.
Micheau C; Boussen H; Klijanienko J; Cvitkovic E; Stosic S; Schwaab G; Eschwege F; Armand JP
Cancer; 1987 Nov; 60(10):2459-64. PubMed ID: 3664429
[TBL] [Abstract][Full Text] [Related]
55. Role of bone scanning in detection of subclinical bone metastasis in nasopharyngeal carcinoma.
Sham JS; Tong CM; Choy D; Yeung DW
Clin Nucl Med; 1991 Jan; 16(1):27-9. PubMed ID: 1999052
[TBL] [Abstract][Full Text] [Related]
56. Ifosfamide/cisplatin-based chemotherapy in metastatic undifferentiated nasopharyngeal carcinoma.
Stein ME; Drumea K
Laryngoscope; 1997 Nov; 107(11 Pt 1):1559. PubMed ID: 9369408
[No Abstract] [Full Text] [Related]
57. [Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies].
Monfort JB; Mathian A; Amoura Z; Francès C; Barbaud A; Senet P
Ann Dermatol Venereol; 2018 Jan; 145(1):33-36. PubMed ID: 28917576
[TBL] [Abstract][Full Text] [Related]
58. Subdural empyema post-chemoradiotherapy for nasopharyngeal carcinoma.
Chan DB; Ong CK; Soo RL
Singapore Med J; 2006 Dec; 47(12):1089-91. PubMed ID: 17139409
[TBL] [Abstract][Full Text] [Related]
59. Superscan in patients with nasopharyngeal carcinoma.
Liu RS; Chu YK; Chu LS; Yeh SH; Yen SH; Chen KY; Chen YK; Shen YY
Clin Nucl Med; 1996 Apr; 21(4):302-6. PubMed ID: 8925613
[TBL] [Abstract][Full Text] [Related]
60. [Positive rate of radionuclide bone imaging and treatment in no ostalgia patients with new nasopharyngeal carcinoma].
Mo HY; Zhang F; Hong MH; Fan W; Zheng L; Min HQ
Ai Zheng; 2002 Mar; 21(3):323-5. PubMed ID: 12452005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
